NASDAQ:IDXX
IDEXX Laboratories Stock News
$468.04
-24.72 (-5.02%)
At Close: May 01, 2024
Idexx Laboratories (IDXX) Surpasses Q2 Earnings Estimates
11:45am, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Idexx (IDXX) delivered earnings and revenue surprises of 1.30% and 0.43%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q2 2022 Results - Earnings Call Transcript
10:01am, Tuesday, 02'nd Aug 2022
IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q2 2022 Earnings Conference Call August 2, 2022 8:30 AM ET Company Participants Brian McKeon - Executive Vice President, Chief Financial Officer & Treasurer Jay
Idexx Laboratories (IDXX) Surpasses Q2 Earnings Estimates
09:05am, Tuesday, 02'nd Aug 2022
Idexx (IDXX) delivered earnings and revenue surprises of 1.30% and 0.43%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Quotient (QTNT) to Report a Decline in Earnings: What to Look Out for
02:03pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Quotient (QTNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OCPNY or IDXX: Which Is the Better Value Stock Right Now?
03:40pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
OCPNY vs. IDXX: Which Stock Is the Better Value Option?
OCPNY or IDXX: Which Is the Better Value Stock Right Now?
01:57pm, Wednesday, 27'th Jul 2022
OCPNY vs. IDXX: Which Stock Is the Better Value Option?
3 MedTech Stocks That are Likely to Beat This Earnings Season
12:23pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how STE, TMO and IDXX are poised ahead of their earnings releases.
IDEXX (IDXX) to Report Q2 Earnings: What's in the Cards?
04:46pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
IDEXX's (IDXX) Q2 performance will likely benefit from strong sales from the CAG Diagnostics and Water businesses.
Idexx Laboratories (IDXX) Expected to Beat Earnings Estimates: Should You Buy?
02:01pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2022
02:22pm, Monday, 25'th Jul 2022 Benzinga
Upgrades
For AutoNation Inc (NYSE:AN), Seaport Global upgraded the previous rating of Neutral to Buy. In the second quarter, AutoNation showed an EPS of $6.48, compared to $4.83 from the year-ago quar
Where IDEXX Laboratories Stands With Analysts
06:22pm, Thursday, 21'st Jul 2022 Benzinga
Analysts have provided the following ratings for IDEXX Laboratories (NASDAQ:IDXX) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
2
2
0
Can Idexx (IDXX) Keep the Earnings Surprise Streak Alive?
04:10pm, Thursday, 21'st Jul 2022 Zacks Investment Research
Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2022
02:06pm, Thursday, 21'st Jul 2022 Benzinga
Upgrades
According to Janney Montgomery Scott, the prior rating for Berkshire Hills Bancorp Inc (NYSE:BHLB) was changed from Neutral to Buy. Berkshire Hills Bancorp earned $0.51 in the second quarter,
Tesla to $1,175? Here Are 5 Other Price Target Changes for Thursday
11:20am, Thursday, 21'st Jul 2022 Benzinga
Mizuho raised Tesla, Inc. (NASDAQ: TSLA) price target from $1,150 to $1,175. However, Mizuho analyst Vijay Rakesh maintained a Buy rating on the stock. Tesla shares rose 3.3% to $766.88 in pre-mark
Here's why Britain's Warren Buffett is sticking with Facebook's parent and other beaten down techs
12:45pm, Friday, 15'th Jul 2022 MarketWatch
Terry Smith, one of the City of London’s most high profile fund managers, has a straightforward approach.